| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Rauer, B Euler, M Reindl, Th Berge. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. Journal of neurology, neurosurgery, and psychiatry. vol 77. issue 6. 2006-05-25. PMID:16705196. |
to investigate whether the presence of serum antibodies against myelin oligodendrocyte glycoprotein (mog) and myelin basic protein (mbp) in patients with a clinically isolated syndrome (cis) predicts the interval to develop more frequently and earlier a first relapse (clinically definite multiple sclerosis: cdms) than seronegative patients. |
2006-05-25 |
2023-08-12 |
Not clear |
| Trevor J Kilpatrick, Helmut Butzkueven, Ben Emery, Mark Marriott, Bruce V Taylor, Niall Tubrid. Neuroglial responses to CNS injury: prospects for novel therapeutics. Expert review of neurotherapeutics. vol 4. issue 5. 2006-04-18. PMID:15853513. |
the neurological disability that all too frequently accompanies multiple sclerosis is ultimately due to injury to target cells, principally oligodendroglia, within the nervous system. |
2006-04-18 |
2023-08-12 |
Not clear |
| Patrice H Lalive, Til Menge, Cecile Delarasse, Bruno Della Gaspera, Danielle Pham-Dinh, Pablo Villoslada, H-C von Büdingen, Claude P Genai. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. vol 103. issue 7. 2006-04-07. PMID:16461459. |
antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. |
2006-04-07 |
2023-08-12 |
human |
| Avraham Ben-Nun, Nicole Kerlero de Rosbo, Nathali Kaushansky, Miriam Eisenstein, Lydia Cohen, Joel F Kaye, Itzhack Mende. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. European journal of immunology. vol 36. issue 2. 2006-03-24. PMID:16453383. |
myelin oligodendrocyte glycoprotein (mog) is an important myelin target antigen, and mog-induced eae is now a widely used model for multiple sclerosis. |
2006-03-24 |
2023-08-12 |
mouse |
| Ikuo Tsunoda, Jane E Libbey, Li-Qing Kuang, Emily Jane Terry, Robert S Fujinam. Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. The American journal of pathology. vol 167. issue 6. 2006-03-08. PMID:16314476. |
using myelin oligodendrocyte glycoprotein (mog)(92-106), we have established animal models that mimic the different types of multiple sclerosis. |
2006-03-08 |
2023-08-12 |
mouse |
| Ajaib S Paintlia, Manjeet K Paintlia, Mushfiquddin Khan, Timothy Vollmer, Avtar K Singh, Inderjit Sing. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 19. issue 11. 2006-03-06. PMID:16126908. |
hmg-coa reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. |
2006-03-06 |
2023-08-12 |
Not clear |
| Ajaib S Paintlia, Manjeet K Paintlia, Mushfiquddin Khan, Timothy Vollmer, Avtar K Singh, Inderjit Sing. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 19. issue 11. 2006-03-06. PMID:16126908. |
impaired remyelination due to degeneration of both postmitotic oligodendrocytes and oligodendrocyte progenitors (ops) is the major hallmark of inflammatory demyelination in multiple sclerosis (ms) lesions and experimental autoimmune encephalomyelitis (eae). |
2006-03-06 |
2023-08-12 |
Not clear |
| Kakuri M Omari, Gareth John, Richard Lango, Cedric S Rain. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia. vol 53. issue 1. 2006-02-24. PMID:16086366. |
as part of a need to understand myelin repair mechanisms, molecular pathways underlying oligodendrocyte behavior and central nervous system (cns) remyelination are currently key topics in multiple sclerosis (ms). |
2006-02-24 |
2023-08-12 |
human |
| N Norgren, A Edelstam, T Stigbran. Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis. Brain research bulletin. vol 67. issue 4. 2006-01-17. PMID:16182933. |
experimental autoimmune encephalomyelitis (eae) induced by myelin oligodendrocyte glycoprotein (mog) is a chronic relapsing-remitting animal model of multiple sclerosis (ms). |
2006-01-17 |
2023-08-12 |
rat |
| J C V M Copray, B M Küst, I Mantingh-Otter, H W G M Boddek. p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice. Neuropathology and applied neurobiology. vol 31. issue 6. 2006-01-10. PMID:16281908. |
the process of oligodendrocyte apoptosis in this animal model for multiple sclerosis (ms) involves early microglial activation, but no infiltration of t-lymphocytes. |
2006-01-10 |
2023-08-12 |
mouse |
| Jürgen Haas, Andreas Hug, Andrea Viehöver, Benedikt Fritzsching, Christine S Falk, Andrea Filser, Tina Vetter, Linda Milkova, Mirjam Korporal, Brigitte Fritz, Brigitte Storch-Hagenlocher, Peter H Krammer, Elisabeth Suri-Payer, Brigitte Wildeman. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. European journal of immunology. vol 35. issue 11. 2005-12-29. PMID:16206232. |
reduced suppressive effect of cd4+cd25high regulatory t cells on the t cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. |
2005-12-29 |
2023-08-12 |
human |
| Dimitrios-Petrou Bogdanos, Heather Smith, Yun Ma, Harold Baum, Giorgina Mieli-Vergani, Diego Vergan. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clinical & developmental immunology. vol 12. issue 3. 2005-12-23. PMID:16295528. |
on the basis of the reported association between hepatitis b vaccination (hbvacc) and autoimmune demyelinating complications such as multiple sclerosis (ms), we have looked for aminoacid similarities between the small hepatitis b virus surface antigen (shbsag), and the ms-autoantigens myelin basic protein (mbp) and myelin oligodendrocyte glycoprotein (mog) that could serve as targets of immunological cross-reactivity. |
2005-12-23 |
2023-08-12 |
human |
| Kevin C O'Connor, Heiner Appel, Lisa Bregoli, Matthew E Call, Ingrid Catz, Jennifer A Chan, Nicole H Moore, Kenneth G Warren, Susan J Wong, David A Hafler, Kai W Wucherpfenni. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. Journal of immunology (Baltimore, Md. : 1950). vol 175. issue 3. 2005-10-26. PMID:16034142. |
autoantibodies to myelin oligodendrocyte glycoprotein (mog) can induce demyelination and oligodendrocyte loss in models of multiple sclerosis (ms). |
2005-10-26 |
2023-08-12 |
human |
| E T Lim, T Berger, M Reindl, C M Dalton, K Fernando, G Keir, E J Thompson, D H Miller, G Giovannon. Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 11. issue 4. 2005-09-26. PMID:16042235. |
this study investigates whether the presence of serum and plasma anti-myelin oligodendrocyte glycoprotein (mog) and anti-myelin basic protein (mbp) in patients presenting with a clinically isolated syndrome compatible with demyelination (cis) predicts early conversion to multiple sclerosis (ms). |
2005-09-26 |
2023-08-12 |
Not clear |
| A K Foote, W F Blakemor. Repopulation of oligodendrocyte progenitor cell-depleted tissue in a model of chronic demyelination. Neuropathology and applied neurobiology. vol 31. issue 4. 2005-09-06. PMID:16008821. |
some, but not all, chronically demyelinated multiple sclerosis (ms) lesions are depleted of oligodendrocyte progenitor cells (opcs) suggesting that opcs are destroyed during the process of demyelination and some factor impedes opc repopulation of the depleted tissue. |
2005-09-06 |
2023-08-12 |
rat |
| Jacqueline Trotte. NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases. Journal of the neurological sciences. vol 233. issue 1-2. 2005-08-22. PMID:15949494. |
some multiple sclerosis patients have autoantibodies to ng2 in the cerebral spinal fluid: such antibodies could interfere with remyelination by lysing oligodendrocyte progenitor cells or blocking their migration but may also cause pathology by disrupting glial-neuronal signalling at synapses and paranodes. |
2005-08-22 |
2023-08-12 |
Not clear |
| Hans Lassman. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. Journal of the neurological sciences. vol 233. issue 1-2. 2005-08-22. PMID:15949497. |
furthermore, recent findings on the pathogenesis of multiple sclerosis lesions indicate that major problems in this disease rather are related to axonal pathology and neurodegeneration rather than to the absence of oligodendrocyte progenitor cells within the lesions. |
2005-08-22 |
2023-08-12 |
Not clear |
| Anuradha Chakrabarty, Kandace K Fleming, Janet G Marquis, Steven M LeVin. Quantifying immunohistochemical staining of phospho-eIF2alpha, heme oxygenase-2 and NADPH cytochrome P450 reductase in oligodendrocytes during experimental autoimmune encephalomyelitis. Journal of neuroscience methods. vol 144. issue 2. 2005-08-18. PMID:15910982. |
as a consequence of inflammation associated with multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (eae), stress responses are induced in many cells within the cns, however, those that occur within the primary pathological target, the oligodendrocyte, are not fully established. |
2005-08-18 |
2023-08-12 |
Not clear |
| Wolfgang Brück, Christine Stadelman. The spectrum of multiple sclerosis: new lessons from pathology. Current opinion in neurology. vol 18. issue 3. 2005-08-09. PMID:15891403. |
this review will focus on recent developments in multiple sclerosis (ms) pathology with particular emphasis on the patterns and mediators of lesion formation in ms, the mechanisms of oligodendrocyte and axon damage and the magnetic resonance imaging-pathological correlation of ms lesions. |
2005-08-09 |
2023-08-12 |
Not clear |
| Francesco Angelucci, Massimiliano Mirabella, Giovanni Frisullo, Marcella Caggiula, Pietro Attilio Tonali, Anna Paola Batocch. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy. Disease markers. vol 21. issue 2. 2005-07-28. PMID:15920290. |
antibodies against myelin oligodendrocyte antigens have been found in the immunoreactive brain lesions of multiple sclerosis (ms) patients. |
2005-07-28 |
2023-08-12 |
Not clear |